The Global Exposome Summit - 27-29 April, 2026. Sitges (Barcelona)
The Global Exposome Summit imagen

Presentation

The Global Exposome Summit

The growing number of human exposome research programmes and projects in recent years has boosted research output and led to the creation of new initiatives and infrastructures worldwide. Yet, cooperation and support between these initiatives remains sporadic and elusive. To bridge this gap, the International Human Exposome Network (IHEN) and the Global Exposome Forum (GEF) are joining forces to organise the Global Exposome Summit 2026.

The Global Exposome Summit 2026 will promote international research and coordination on the exposome. It will bring together researchers, policymakers, industry, funders, and other stakeholders working on advancing human health through exposome research and practice.

Participants will have the opportunity to hear from prominent keynote speakers, interact with experts and innovators in the field, and learn more about the latest exposome science and practice. The summit will also offer young researchers a chance to present and discuss their latest findings.

A part of the summit will be dedicated to the building of a global community, sharing key resources and data infrastructures, and continuing work on a roadmap for future exposome research and global collaboration.

Organised as a follow-up to the Exposome Moonshot Forum meeting in May 2025, the summit will include working group sessions, poster presentations, debates, and plenary sessions dedicated to advancing this global initiative.

We look forward to welcoming you in Sitges (Barcelona, Spain) in April 2026!

The Global Exposome Summit

The event starts in:

  • days
  • hours
  • minutes
  • seconds

Important Dates

11 December,
2025
11 December, 2025 Registration opens
Registrations »
14 January,
2026
14 January, 2026 Abstract submission closes
Abstracts »
2 February ,
2026
2 February, 2026 Acceptance notification
Abstracts »
23 February,
2026
23 February, 2026 Reduced rate ends
Registrations »
28 February,
2026
23:59h CET
28 February, 2026 23:59h CET Abstract submissions for late-breaking posters
Abstracts »
27-29 April,
2026
27-29 April, 2026 Conference dates
Programme »
The Global Exposome Summit - 27-29 April, 2026. Sitges (Barcelona)

The event (Summit)

The Global Exposome Summit

The Global Exposome Summit
Scientific committee
Local organising committee

Chair

Martine Vrijheid. Barcelona Institute for Global Health (ISGlobal), Spain

Vice-chairs

Roel Vermeulen. Utrecht University, Netherlands
Gary Miller. Columbia University, USA
Fenna Sillé. Johns Hopkins University,USA

Members

Jana Klanova. Masaryk University, Czech Republic
Xavier Coumoul. Inserm / Université Paris Cité, France
Sylvain Sebert. University of Oulu, Finland
Zisis Kozlakidis. International Agency for Research on Cancer / WHO
Konstantinos Makris. Cyprus University of Technology, Cyprus
Denis Sarigiannis. Aristotle University of Thessaloniki, Greece
Myriam Mrad. Health & Environment Response Agency, Lebanon
Rafael Buralli. University of São Paulo, Brazil
Yu Ait Bamai. Hokkaido University, Japan

Members

Rodney Ortiz. Barcelona Institute for Global Health (ISGlobal)
Augusto Anguita. Barcelona Institute for Global Health (ISGlobal)
Parisa Montazeri. Barcelona Institute for Global Health (ISGlobal)
Sara Stanulovic. Barcelona Institute for Global Health (ISGlobal)
Julianna Angelova. Health and Environment Alliance (HEAL)
Helena Uhl. Health and Environment Alliance (HEAL)
Oriol Setó. ACTOserveis
Luna Grinschpun. ACTOserveis

Sponsored by

In collaboration with

Host Organisation

ISGlobal

Partners

JHU-CAAT
NEXUS
EIRENE
Utrecht University
Muni Recetox
Inserm
UMCG
IARC
CUT
University of Oulu
Heal
Anses
hera
Aristotle University of Thessaloniki

Programme

Monday, 27 April 2026. Operationalising the Exposome – Policy, Tools, and the Road Ahead

08.30 - 09.00 h Registration, welcome, coffee
09.00 - 10.30 h Opening session - Setting the scene
  • Opening remarks
    Roel Vermeulen. Utrecht University: Framing the exposome as a bridge between science and policymaking
  • Keynote address 1
    Christophe Clergeau. Member of European Parliament
  • Keynote address 2
    Francesca Racioppi. WHO Regional Office for Europe | European Centre for Environment and Health
  • Keynote address 3
    Alex Mulet. Directorate-General for Research and Innovation (DG-RTD), European Commission
  • Q & A
10.30 - 11.00 h Break
11.00 - 13.00 h Exposome: Europe’s strategic advantage for health, data and competitiveness (panel discussions)
  • Panel 1: Europe’s next health flagship: A Mission Exposome for Research, Innovation & Competitiveness
  • Panel 2: Building the European Exposome Data Space: Connecting Environment, Health and Social data for prevention
  • Panel 3: Cities, Built Environments & Chemicals: Real-World Exposures and the Case for Coordinated EU Action
  • Panel 4: A European Common Prevention Pillar: coordinating policies across the life course using the exposome
  • Closing Remarks
13.00 - 14.00 h Break
14.00 - 15.30 h Deployable exposome tools and infrastructures
  • Introduction: The federated ecosystem and the paths towards exposome research and policies in the European Region
    Sylvain Sebert. University of Oulu.
  • FAIR exposome maps and tools: State-of-play and case study
    Justiina Ronkainen.University of Oulu.
    Hüseyin Küçükali. Utrecht University.
  • FAIR Exposome Cohort Catalogues: State-of-play and case study
    Eleanor Hyde. UMCG.
    Augusto Anguita-Ruiz. ISGlobal.
  • Call for Action: Empowering the European Exposome Research Environment through global cooperation, participation and engagement
    Rafael Buralli. University of São Paulo.
    Yu Ait Bamai. Hokkaido University
  • Discussion
15.30 - 16.00 h Break
16.00 - 17.30 h Exposome research roadmap & regional priorities
  • General overview
    Roel Vermeulen. Utrecht University.
    Manel Rihani. ANSES.
  • Goal 1: How does global change impact the exposome
    Léa Maitre. ISGlobal.
  • Goal 2: How transitions affect the exposome
    Utrecht Univesity.
  • Goal 3: How can the exposome support public health policy/regulation
    Manel Rihani. ANSES.
  • Goal 4: How can the exposome improve medicine
    Tatiana Saad. Inserm.
  • Goal 5: Development of methods, tools, infrastructures
    Utrecht University.
  • Global perspectives from Africa, Asia, Latin America and USA
    Meaza Shentema. Addis Ababa University.
    Diana Marcela Marín Pineda. Universidad Pontificia Bolivariana.
    Gary Miller. Columbia University.
  • Discussion
18:00 - 19:00 h Welcome reception and networking

Tuesday, 28 April 2026. Exposome Science

09.00 - 10.30 h Scientific session 1 - keynotes and selected abstracts
  • Keynote 1: Climate action as a driver of healthier exposomes
    Cathryn Tonne. ISGlobal, Barcelona, Spain
  • Keynote 2: From Sample to Molecules to Meaning: High-Resolution Chemical Exposomics for Precision Health
    Jonathan Martin. Stockholm University, Sweden
  • Abstract presentation 1: Developing An Integrative Exposomics Platform (ExposomeX) to Expedite Discovery of "Exposure-Biology-Disease" Nexus
    Bin Wang. Peking University, China
  • Abstract presentation 2: Exploring the exposome and the unexplained variance in biological ageing – insights from a genetically controlled twin study in early adulthood
    Annika Opperbeck. University of Jyväskylä, Finland
10.30 - 11.00 h Break
11.00 - 11.30 h Poster presentations 1
11.30 - 13.00 h Scientific session 2 - keynotes and selected abstracts
  • Keynote 3: Integrating Consumer Product-Based Exposure with AOP-Anchored AI-Based Toxicity Prediction for Exposome-Informed Chemical Prioritization
    Jinhee Choi. University of Seoul, South Korea
  • Abstract presentation 3: Brain Exposomics Reveals Dietary Lipids Linked to Reduced Alzheimer's Disease Neuropathology
    Donghai Liang. Emory University, USA
  • Abstract presentation 4: A Novel Causal Discovery-based Exposome Analysis Pipeline: Screening for Causally Influential Pregnancy Exposures Driving Fetal Growth
    Navin Michael. A*STAR, National University of Singapore
  • Abstract presentation 5: Advancing Urban Microbial Exposome for Planetary Health
    Marja Roslund. Natural Resources Institute, Finland
  • Abstract presentation 6: From Exposome Domains to Health and Mortality: Estimating Attributable Risks and Proportions Mediated by Biomarkers
    Helene Colineaux. Imperial College London, UK
13.00 - 14.00 h Break
14.00 - 14.30 h Poster presentations 2
14.30 - 15.00 h Poster presentations 3
15.00 - 16.00 h Scientific session 3 - keynotes and selected abstracts
  • Keynote 4: Advances in Spatiotemporal Modelling for External Exposome Assessment
    Kees de Hoogh. Utrecht University, Netherlands
  • Abstract presentation 7: Early life social and environmental exposures and all-cause hospital visits among children under five in Southern Mozambique
    Stefan Sieber. ISGlobal, Barcelona, Spain
  • Abstract presentation 8: From the environment to the heart: Joint effects of long-term external exposome on ischemic heart disease incidence in Europe
    Huyen Nguyen Thi Khanh. Karolinska Institutet, Stockholm, Sweden
16.00 - 16.30 h Break
16.30 - 18.00 h Scientific session 4 - keynotes and selected abstracts
  • Keynote 5: Unequal exposomes shaping global brain health
    Joaquin Migeot. Latin American Brain Health Institute (BrainLat), Chile
  • Keynote 6: From Exposures to Outcomes: A Multi-Omics Window into the Infant Gut Microbiome
    Tanya Alderete. Johns Hopkins University, USA
  • Abstract presentation 9: Artificial Intelligence for Identifying Treatable Exposomic Root Causes of Chronic Disease
    Krisna Bhargava. The Exposome Intelligence Company - New York, USA
  • Abstract presentation 10: Effect-based human biomonitoring of complex chemical mixtures in human matrices
    Georg Braun. Helmholtz-Centre for Environmental Research (UFZ), Leipzig, Germany
18:15 - 19.00 Open meeting: Microsampling in exposomics: where we stand and how to move forward
Moderators:
Jos Bessems. VITO
Vinicius Verri Hernandes. University of Vienna
19:30 Summit Dinner

Wednesday, 29 April 2026. Building the Global Exposome Community

08.30 - 08.55 h GEF Plenary session 1: Framing the Discussion
09.00 - 10.00 h GEF Parallel sessions 2A, 2B, 2C, 2D
  • 2A: Chemical and biological analytics
    Jon Martin. Stockholm University.
    Benedikt Warth. University of Vienna.
    Jessica Ewald. EMBL-EBI.
    Dinesh Barupal. Icahn School of Medicine at Mount Sinai.
    Lauren Petrick. Icahn School of Medicine at Mount Sinai.
  • 2B: Geospatial methods and applications
    Rima Habre. University of Southern California.
    Kees de Hoogh. Utrecht University.
    Itai Kloog. Icahn School of Medicine at Mount Sinai.
    Jean-Baptiste Guimbaud. Meersens.
    Hüseyin Küçükali. Utrecht University.
    Anne Thessen. University of North Carolina - Chapel Hill.
    Thahn H. (Helen) Nguyen. University of Illinois - Urbana Champaign .
  • 2C: Wearables
    Krystal Pollitt. Yale University.
    Thomas Hankemeier. Leiden University.
    Chao Jiang. Zhejiang University.
  • 2D: ExWAS and Big data / AI
    Chirag Patel. Harvard University.
    Alison Motsinger-Reif. NIEHS.
    Vasilis Vasiliou. Yale University.
    Heidi Hanson. Oak Ridge National Laboratory.
    Marc Chadeau-Hyam. Imperial College London.
    John P.A. Ioannidis. Stanford University.
    Mingliang Fang. Fudan University.
    Arjun Manrai. Harvard University.
    Karim Lekadir. University of Barcelona .
10.00 - 10.30 h Break
10.30 - 11.25 h GEF Plenary session 3: Partnering for Success
Fenna Sillé. Johns Hopkins University
John Randell. Human Cell Atlas
Casimiro Vizzini. UNESCO
Milena Foerster. IARC
Floriane Pereira. Biocodex Microbiota Institute
11.30 - 12.30 h GEF Parallel sessions 4A, 4B, 4C, 4D
  • 4A: Exposomics in practice: Cities as testbeds
    Roel Vermeulen. Utrecht University.
    Tina Woods. Collider Health.
    Denis Sarigiannis. National Hellenic Research Foundation / Aristotle University of Thessaloniki.
    Song Tang. National Institute of Environmental Health - China CDC.
    Chris Edmond. WorkHealth Jersey.
    Mark Nieuwenhuisen. ISGlobal.
    Agis Tsouros. Boston University.
  • 4B: Exposomics in practice: Individual exposomics (& precision health)
    Socrates Papageorgiou. University of Athens.
    Manish Arora. Icahn School of Medicine at Mount Sinai.
    Carmen Messerlian. Vie Institute for Generational Health / Harvard University.
    Zodwa Dlamini. Pan Africa Cancer Research Institute (PACRI) / University of Pretoria.
    Fady Hannah-Shmouni. The University of British Columbia.
    Shai Shen-Orr. Technion.
  • 4C: Exposomics in practice: Next steps for cohorts
    Martine Vrijheid. ISGlobal.
    Yu Ait Bamai. Hokkaido University.
    Zisis Kozlakidis. IARC/WHO.
    Lida Chatzi. USC.
    Shoji Nakayama. Japan Environment and Children’s Study / National Institute for Environmental Studies.
12.30 - 13.30 h Break
13.30 - 14.25 h GEF Plenary session 5: Exposome and policy: creating insightful, actionable and ethical solutions
Jeanette Stingone. Columbia University
Ming Yang. Nature Publishing
Denis Naughten. Innosphere Consulting
Remí Quirion. Ministère de l’Économie, de l’Innovation et de l’Énergie du Québec
Xiaoming Shi. National Institute of Environmental Health - China CDC
Eleonora Chinchio. Joint Research Centre, European Commission
Caspar Safarlou. University Medical Center Utrecht
14.30 - 15.30 h Plenary closing session, next steps

Poster
presentations


Poster Distribution Overview Poster Distribution Overview

Poster Table

Poster presentations 1

11.00 - 11.30 h Group 1.1. Urban Exposome & Health (Konstatinos Makris)
Tramuntana Room
  • Long-term Air Pollution Exposure Accelerates Biological Aging and Mediates Clinical Outcomes: A Multi-Cohort Exposome Analysis (P-123)
    Parinaz Poursafa — Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland; +
  • Beyond Greenness: Multidimensional Urban Nature Profiles and Arteriosclerotic Cardiovascular Risk (P-124)
    Pablo Knobel — Department of Environmental Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA; +
  • External exposome, social disadvantage and biological ageing in the UK general population (P-125)
    Gergo Baranyi — UCL Centre for Longitudinal Studies; +
  • Individual and joint associations of multiple environmental exposures with diabetes and obesity in the population-based German National Cohort (NAKO) (P-126)
    Fiona Niedermayer — Chair of Epidemiology, IBE, Faculty of Medicine, Ludwig-Maximilians-Universität Munich, Munich, Germany; +
  • A geospatial framework for the preliminary characterization of urban exposomes to support health-associated population studies across Europe (P-127)
    João S. Lopes — Galicia Sur Health Research Institute (IIS Galicia Sur), SERGAS-UVIGO; +
  • Perceived environmental noise and air pollution, urban environment and hypertension in South Africa (P-128)
    Yonela Mkunyana — Environment and Health Research Unit, South African Medical Research Council, Cape Town, South Africa; +
  • Advancing Human Exposome Research in the German National Cohort (NAKO) (P-129)
    Susanne Breitner-Busch — Institute of Epidemiology, Helmholtz Zentrum München - German Research Center for Environmental Health; +
  • The Urban Exposome and Social Determinants in CARDIA (P-130)
    Laura Jones — University at Albany; +
  • A GIS-Based Framework for Urban Exposome Assessment Using Secondary Data: Illustrated with Algiers, Algeria (P-131)
    khelil cherfi khadidja — University Blida 1 (Institute of architecture & urbanism, ETAP Lab); +
11.00 - 11.30 h Group 1.2. Urban Exposome & Molecular Signatures (Sylvain Sebert)
Tramuntana Room
  • Exposome–metabolome interactions shaping cardiometabolic risk phenotypes in children with obesity (P-162)
    Mahsa Naghavi Sheikholeslami — Institut d'Investigació Sanitària Pere Virgili, Reus, Spain; +
  • Investigating the association between geographical distance and epigenetic differences in two Italian birth cohorts (P-163)
    Maja Popovic — Cancer Epidemiology Unit, Department of Medical Sciences and CPO-Piemonte, University of Turin, Turin, Italy; +
  • Metabolomic signatures of air pollution exposure across the life-course (P-164)
    Ana Gonçalves Soares — MRC Integrative Epidemiology Unit, University of Bristol; +
  • External exposome and metabolite associations in 152,000 participants of the Estonian Biobank (P-165)
    Hanna-Maria Kukk — Institute of Genomics, University of Tartu; +
  • Deciphering urban exposome mechanisms through high-dimension biology: Insights from the URBANOME project (P-166)
    Alberto Gotti — Environmental Engineering Laboratory, Department of Chemical Engineering, Aristotle University of Thessaloniki, Thessaloniki, Greece, EUCENTRE, Via Adolfo Ferrata, 1, Pavia 27100, Italy; +
  • Embodiment of the Exposome in Ageing: Pathways to Cardiovascular Risk (P-167)
    Rin Wada — Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London; +
  • Mediation analysis from high-dimensional data identifies proximal and distal exposomic risk factors driving embodiment of cardiovascular disease risk in the UK Biobank. (P-168)
    Ruben Colindres Zuehlke* — Epidemiology and Biostatistics, School of Public Health, Imperial College London; +
  • Air pollution and placental biomarkers of oxidative stress and ageing: results from the BiSC cohort (P-169)
    Laura Gómez-Herrera — ISGlobal, Barcelona Institute for Global Health, Barcelona, Spain; +
11.00 - 11.30 h Group 1.3. Early Life Exposome (Parisa Montazeri)
Hall Tramuntana
  • Prenatal Antibiotic Exposure and Gestational Diabetes Mellitus in a Prospective Cohort Study: The Role of Lipopolysaccharide (P-54)
    Ziyuan Qi — MOE Key Laboratory of Environmental Remediation and Ecosystem Health, College of Environmental and Resource Sciences, Zhejiang University;
  • Maternal chrono-nutrition and placental DNA methylation: the BiSC study (P-55)
    Sofia Aguilar — ISGlobal, Barcelona, Spain; +
  • Does Maternal Diet Influence Atopic and Respiratory Health Outcomes in Early Life? (P-56)
    Carolin Huber — Department of Exposure Science, Helmholtz Centre for Environmental Research – UFZ, Leipzig, Germany; +
  • Prenatal Exposome, Genetic Factors, and Child Behavior: Results from the Taiwan Birth Panel Study (P-57)
    Mei-Huei Chen — Institute of Population Health Sciences, National Health Research Institutes, Miaoli, Taiwan; +
  • Associations Between Maternal Dietary Patterns and Fetal Cardiac Outcomes (P-58)
    Augusto Anguita-Ruiz — ISGlobal, Barcelona, Spain; +
  • Longitudinal assessment of the exposome and body mass index trajectories during critical developmental years: The CHILDREN_FIRST pilot cohort in Cyprus (P-59)
    Corina Konstantinou — Cyprus International Institute for Environmental and Public Health, School of Health Sciences, Cyprus University of Technology, Limassol, Cyprus; +
  • Prenatal Environmental Determinants of a Morbidity Count in Childhood and Pre-adolescence: A Meta-analysis from Nine European Birth Cohorts (P-60)
    Ines Amine — Université Grenoble Alpes, Inserm U 1209, CNRS UMR 5309, Team of Environmental Epidemiology Applied to the Development and Respiratory Health, Institute for Advanced Biosciences, 38700 La Tronche, France; +
  • Machine Learning Prediction of Preterm Birth Using the Maternal Exposome (P-61)
    Mengyuan Ren — Gangarosa Department of Environmental Health, Rollins School of Public Health, Emory University; +
  • FILOMENE – A new French large couple-child cohort to study the relations between the exposome and children’s health (P-62)
    Barbara Heude — Université Paris Cité et UniversitéSorbonne Paris Nord, Inserm, INRAE, Centre de Recherche en épidémiologie et StatistiqueS (CRESS) – Inserm – 10 Av de Verdun 75010 Paris, France; +
  • An Exposomics and Multi-Omics Analysis of Immune Pathways Associated with Airway Obstruction in Pediatric Asthma (P-63)
    Jason Laird — Center for Alternatives to Animal Testing (CAAT), Johns Hopkins University, Baltimore, MD; +
11.00 - 11.30 h Group 1.4. Chemical Exposome - profiles and determinants 1 (Adrian Covaci)
Tramuntana Room
  • Characterizing oral exposure to micro- and nanoplastics and plastic additives and their determinants in adults: a Barcelona population-based study (P-178)
    Carolina Donat-Vargas — ISGlobal; +
  • Environmental Exposures in Lebanese Infants (EELI): Maternal Determinants of Cord Blood Dichlorodiphenyltrichloroethane (DDT) and Dichlorodiphenyldichloroethylene (DDE) Levels (P-179)
    Jowy Abi Hanna — Institut Supérieur de Santé Publique, Faculty of medicine, Saint-Joseph University of Beirut, Beirut, Lebanon; +
  • Levers to decrease exposure to harmful chemicals: the case of Personal Care Products and cosmetics (P-180)
    Nicolas Jovanovic — University Grenoble Alpes, Inserm, CNRS, Team of Environmental Epidemiology applied to Reproduction and Respiratory Health, Institute for Advanced Biosciences (IAB), Grenoble, France; +
  • SOCIOECONOMIC, LIFESTYLE, AND ENVIRONMENTAL DETERMINANTS OF THE CHEMICAL EXPOSOME IN PREGNANT WOMEN FROM BARCELONA (P-181)
    Esteban Restrepo-Montes — Environmental Chemistry Department, Institute of Environmental Assessment and Water Research, IDAEA-CSIC, Barcelona, Spain; +
  • Cross-population comparisons of the chemical exposome in participants of the Human Health Exposure Analysis Resource (P-182)
    Dillon T. Lloyd — Department of Biomedical Informatics, Harvard Medical School; +
  • Associations between Lifestyle Trends and Exposure to Endocrine-Disrupting Chemicals in Children (P-183)
    Nicola Montemurro — IDAEA-CSIC; +
11.00 - 11.30 h Group 1.5. Wearables and sensors (Krystal Pollitt)
Hall Auditorium
  • Exposometer-based assessment of laboratory work environment (P-01)
    Helena Andersson — Department of Clinical Science, Intervention and Technology (Karolinska Institutet); +
  • AI-Driven Primary Prevention: Environmental Signatures in Workplaces via Sensor-Based Monitoring Across Sectors (P-02)
    Jean-Baptiste Guimbaud — Meersens; +
  • Longitudinal monitoring of dietary exposome effects on metabolism with at-home dried blood sampling (P-03)
    M. Gordian Adam; +
  • Mapping the Pediatric Exposome: Using Silicone Wristbands as Passive Sampling Tools for Environmental Exposure Assessment in Children (P-04)
    Amith Sadananda Maroli — Department of Environmental Medicine, Icahn School of Medicine at Mount Sinai, NY, USA; +
  • Personalized airborne exposomes reshape host molecular systems in a space-analog confined environment (P-05)
    Zinuo Huang — Life Sciences Institute, Zhejiang University; +
  • Mapping the personal early-life atmosome using silicone wristbands: a comprehensive wide-scope suspect screening UHPLC-HRMS and GC-HRMS approach (P-06)
    Camilla Guerrini — Institut de Recerca Biomèdica Catalunya Sud (IRB CatSud); +
  • Measuring the Exposome: A Practical Guide for Using Wearable Passive Samplers to Assess Environmental Influences (P-07)
    Joseph Okeme — Department of Chemistry and Chemical Biology, McMaster University; +
  • Geographic and behavioural diversity in the optical radiation exposome (P-08)
    Sam Aerts — Smart Sensor Systems research group, The Hague University of Applied Sciences; +
  • Mapping of long-term biotic and abiotic exposures among pregnant women (P-09)
    Allison Zhang — Department of Genetics, Stanford University, US; +
  • From fire line to brain cells (P-10)
    Carmen Bedia — Institute of Environmental Assessment and Water Research (IDAEA-CSIC), Dept. Environmental Chemistry;
11.00 - 11.30 h Group 1.6. Indoor exposome (Emma Julliet)
Tramuntana Room
  • Integrated Indoor Exposure and Diet Assessment and Human Biomonitoring of Metals: Preliminary Results from the LëtzHBM survey under PARC (P-100)
    Torres Toda M — Laboratoire national de santé (LNS), Department Health Protection, Service Medical Expertise and Data Intelligence, 1 Rue Louis Rech, L-3555 Dudelange, Luxembourg; +
  • Smoke and Plasma Metabolomic Signatures in Los Angeles–Area Residents (P-101)
    Youn Soo Jung — Harvard T.H. Chan School of Public Health; +
  • Indoor Exposure Assessment of Chemical and Physical Stressors in Croatian Households (P-94)
    Mario Lovrić — Lisbon Council, Institute for Anthropological Research; +
  • Pan-European Characterization of the Human Airborne Chemical Exposome by GC- and LC-HRMS using PDMS-Foam Passive Sampling (P-95)
    Adrià Sunyer-Caldú — Department of Environmental Science, Stockholm University, Stockholm, Sweden; +
  • Identifying Gaps in Exposome Research Using Adverse Outcome Pathways: An Indoor Air Case Study (P-96)
    Emma Juillet — Université Paris Cité; +
  • Size-resolved chemical profiling of airborne particulate matter reveals overlap with the human brain exposome and prioritizes candidate neurotoxicants (P-97)
    Daniel Gutiérrez-Martín — Department of Environmental Chemistry, Institute of Environmental Assessment and Water Research (IDAEA CSIC); +
  • Non-target profiling of PM₂.₅ chemical mixtures in healthcare settings (P-98)
    Mireia Nuñez — Institute of Environmental Assessment and Water Research (IDAEA-CSIC); +
  • Differences in the breathome across nicotine products users identified by thermal desorption-gas chromatography-time-of-flight mass spectrometry (TD-GC-TOF-MS) (P-99)
    Therese Burkhardt — ABF GmbH; +
11.00 - 11.30 h Group 1.7. Mircobiome 1 (Sarah De Saeger)
Tramuntana Room
  • Mixed prenatal exposure to essential and toxic metals are associated with the gut microbiome in late childhood (P-148)
    Shoshannah Eggers — Epidemiology, University of Iowa College of Public Health; +
  • Associations between PAH exposure, bacteriome and type 1 diabetes among genetically susceptible children in highly urbanized regions (P-149)
    Mira Grönroos — Faculty of Biological and Environmental Sciences, Ecosystems and Environment Research programme, University of Helsinki, Finland; +
  • Association Between Urban Exposures and Adolescent Gut Microbiota in European Birth Cohorts (P-150)
    Herrera-Luis; +
  • Tree abundance around home affects human microbiota (P-151)
    Mira Grönroos — Faculty of Biological and Environmental Sciences, University of Helsinki; +
  • Implementation of a governed Data Space for exposome data sharing, including gut microbiome (P-152)
    Sara Eguizábal — Galicia Sur Health Research Institute (IIS Galicia Sur), SERGAS-UVIGO; +
  • The Flemish Exposome Project FLEXiGUT: Unraveling the impact of environmental and dietary contaminants on gut microbiome composition and inflammation (P-153)
    R. Pero-Gascon — Centre of Excellence in Mycotoxicology and Public Health, Ghent University, Belgium; +
  • Characterizing the pediatric exposome to investigate environmental drivers of antimicrobial resistance (P-154)
    Monica Pajuelo — Laboratorio de Microbiología Molecular, Laboratorios de Investigación y Desarrollo, Facultad de Ciencias e Ingeniería, Universidad Peruana Cayetano Heredia, Lima, Peru; +
11.00 - 11.30 h Group 1.8. Data platforms and projects (Hüseyin Küçükali)
Hall Auditorium
  • Applying the FAIR Principles to Personal Exposure and Health Data (P-37)
    Jos Bessems — VITO; +
  • Exposome Correlation and Interpretation Database (ECID) (P-38)
    Dinesh Barupal — Icahn School of Medicine at Mount Sinai;
  • Advancing public health through exposome research (P-39)
    Sigrid C.J. De Keersmaecker — Transversal activities in applied genomics, Sciensano; +
  • Data Infrastructure Linking Genomes, Phenomes, and Exposomes to Support Discovery of Causal Pathways from Exposure to Outcome (P-40)
    Anne E Thessen — Genetics Department, University of North Carolina Chapel Hill; +
  • Personal Exposome Data Centre within the European Environment and Health Research Infrastructure (EIRENE) (P-41)
    Stijn Baken — VITO; +
  • Sante Nou se Avni Nou: A Community Academic collaboration to Decrease Health Disparities in Immigrant Populations (P-42)
    Jovanka Ravix — Department of Ob, Gyn and Reproductive Sciences; +
  • The MOXIE Mega-Omic Atlas: A Framework for Mapping Exposome-Mediated Immune Dysregulation in Chronic Inflammatory Disease (P-43)
    Judith Allen — Manchester Oxford Immunology of the Exposome Centre of Research Excellence, The University of Manchester; +
  • Data Standards and Ontologies for Exposomics: The value of common language, addressing gaps and the way forward (P-44)
    Maria Shatz — Office of Data Science, National Institute of Environmental Health Sciences; +
  • NIACES: African-Led Exposome–Genomic Precision Health for Culturally Grounded Cancer Prevention and Care (P-45)
    Zilungile Mkhize-Kwitshana — Department of Life and Consumer Sciences, College of Agriculture and Science & Environmental Sciences; +

Poster presentations 2

14.00 - 14.30 h Group 2.1. Urban Exposome, Climate & Health (Payam Dadvand)
Tramuntana Room
  • Air Pollution, Genetic Susceptibility, and Atrial Fibrillation Risk in the Multiethnic US Cohort (All of US) (P-79)
    Andrew Craver — Institute for Population and Precison Health , The Univeristy of Chicago; +
  • Climate Change, Exposome, and Maternal-Child Health in Arid Regions: A Qualitative Study in Garissa County, Kenya (P-80)
    Caroline Muthoni — Institute for Human Development, The Aga Khan University; +
  • Outdoor Air pollution Exposure and Epigenetic Age from birth to adolescence – a two stage individual participant data meta-analysis (P-81)
    Mónica López-Vicente — ISGlobal, Barcelona, Spain; +
  • The impact of residential relocation on the urban external exposome (P-82)
    Lara Stucki — Barcelona Institute for Global Health, Barcelona, Spain; +
  • Translating high-level urban exposome science into precision public health: The URBANOME operational framework (P-83)
    Alberto Gotti — Environmental Engineering Laboratory, Department of Chemical Engineering, Aristotle University of Thessaloniki, Thessaloniki, Greece, EUCENTRE, Via Adolfo Ferrata, 1, Pavia 27100, Italy; +
  • Spatiotemporal modelling of daily pollen concentrations and their impacts on allergic symptom severity (P-84)
    Alexandra Bürgler — Swiss Tropical and Public Health Institute, Allschwil, Switzerland; +
  • Understanding the molecular impacts of prenatal wildfire exposure (P-85)
    Beryl Zhuang — University of British Columbia; +
  • Structural Inequality and the Exposome: Differential Multi-Domain Environmental Burden Profiles in Black and Latino Adolescents in the United States (P-86)
    Megan M. Herting — Department of Population and Public Health Sciences, Keck School of Medicine of the University of Southern California; +
14.00 - 14.30 h Group 2.2. Chemical Exposome & Child Health (Yu Ait Bait)
Tramuntana Room
  • Prenatal Insecticide Exposure and Adverse Birth Outcomes: Evidence for Mediation via Disruptions in Amino Acid and Acylcarnitine Metabolism (P-102)
    Yubing Ma — MOE Key Laboratory of Environmental Remediation and Ecosystem Health; +
  • Burden of disease attributable to diet-related chemical exposome in French children (P-103)
    Sarah Cherfan — ANSES, French Agency for Food, Environmental and Occupational Health and Safety, Risk Assessment Department, Methodology and Studies Unit, 947001, Maisons-Alfort, France; +
  • Pregnancy exposure to per- and polyfluoroalkyl substances and placental DNA methylation profile (P-104)
    Hana Vespalcova — ISGlobal, Barcelona, Spain; +
  • Prenatal exposure to plastics and associated chemicals and fetal growth in the BiSC cohort (P-105)
    Bethany Knox — Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain; +
  • The maternal chemical exposome and steroid hormone profiles during pregnancy: Preliminary results using an ExWAS approach (P-106)
    Emily Laveriano-Santos — ISGlobal, Barcelona, Spain | Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Institute of Health Carlos III, Madrid, Spain.; +
  • Per- and Polyfluoroalkyl Substances disrupt metabolic and oligosaccharide composition of human milk across lactation (P-107)
    Nathan Young — Department of Environmental Health and Engineering (Johns Hopkins University); +
  • Prenatal Exposure to Endocrine-Disrupting Chemicals and Biomarkers of Cellular Aging in European Children (P-108)
    #Citlalli Osorio-Yáñez — Institute of Biomedical Research; +
  • Exposure to PFAS mixtures at different developmental periods and liver health in adolescence. (P-109)
    Vishal Midya — Department of Environmental Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA; +
14.00 - 14.30 h Group 2.3. Adult Exposome (Zisis Kozlakidis)
Hall Tramuntana
  • Subjective and Objective Neighborhood-level Social Determinants of Health: A Population-Based Study of the Social Exposome (P-71)
    Sharon Stein Merkin — Gertner Institute, Sheba Medical Center; +
  • Lipid metabolism in biological aging reveals sex-specific links of urinary polycyclic aromatic hydrocarbons to cognitive decline (P-72)
    Wanying Shi — Chinese Center for Disease Control and Prevention; +
  • Quantifying the Social Exposome: Neural State and Biological Stress Pathways in a Pilot JoyScore Experiment (P-73)
    Dr Michael Sagner — Ageing Research, Kings College London; +
  • Measuring the social and environmental exposome influences on DNA Methylation and Inflammation (P-74)
    Michal Engelman — Department of Sociology, University of Wisconsin Madison; +
  • Interim metabolomic analysis associated to cognitive improvements in older adults with mild cognitive impairment: Mediterranean diet versus low-fat diet (P-75)
    Miriam Martínez-Huélamo — Biomarkers, Exposome, and Nutritional & Food Metabolomics Laboratory, Department of Nutrition, Food Sciences and Gastronomy, Nutrition and Food Safety Research Institute (INSA-UB), Faculty of Pharmacy and Food Sciences, University of Barcelona, 08028, Barcelona, Spain; +
  • Enhanced metabolomics-derived aging clocks: a generalization across metabolomics assays and in pregnant and multi-ethnic women (P-76)
    Colicino Elena — Icahn School of Medicine at Mount Sinai, Environmental Medicine, New York, USA; +
  • Dietary intake of polybrominated diphenyl ethers (PBDEs) and the risk of obesity in the French E3N cohort (P-77)
    Xuan Ren — Université Paris-Saclay, UVSQ, Inserm, Gustave Roussy, CESP, Villejuif, France.; +
  • Dietary Polyphenol Exposure and Dementia risk: Prospective Findings from the EPIC-Spain Dementia Study (P-78)
    ;
14.00 - 14.30 h Group 2.4. Chemical Exposome - profiles and determinants 2 (Parisa Montazeri)
Hall Auditorium
  • Skin Absorption and Toxicokinetics of VOCs from Personal Care Products (P-11)
    Ying Zhu — School of Environmental Science and Engineering, Shanghai Jiao Tong University; +
  • Spatial variability in placental tissue shapes the interpretation of the prenatal chemical exposome (P-12)
    Ana González-Ruiz — Institut d’Investigació Sanitària Pere Virgili (IISPV), Tarragona, Spain; +
  • Profiling Early-Life Exposures and Metabolic Profiles in Childhood Obesity in Urine: The EXPOSOME Project (P-13)
    A. Barri — Institut d'Investigació Sanitària Pere Virgili; +
  • Exploring the urinary exposome of smokers, never-smokers and former-smokers by liquid chromatography coupled with high resolution Orbitrap mass spectrometry (P-14)
    Amin Sajid — ABF GmbH; +
  • Assessing the tobacco-related chemical exposome in placenta: The PRENATAL project (P-15)
    Amina Barri — Institut d'Investigació Sanitària Pere Virgili (IISPV); +
  • Chemical exposome in a Flemish birth cohort from the FLEXiGUT Exposome project (P-16)
    Fatima den Ouden — Toxicological Centre, University of Antwerp; +
  • Parenteral nutrition as a source of xenobiotic exposure in preterm infants (P-17)
    Michael Eigenschink — Division of Neonatology, Pediatric Intensive Care & Neuropaediatrics, Department of Pediatrics and Adolescent Medicine, Comprehensive Center for Pediatrics, Medical University of Vienna, Austria; +
  • Creating population-based benchmarks for research on the pregnancy exposome (P-18)
    Jeanette Stingone — Department of Epidemiology, Columbia University; +
14.00 - 14.30 h Group 2.5. Mass-spectrometry methods 1 (Elliott Price)
Hall Tramuntana
  • Scaled-Up Target and Nontarget Chemical Exposomics Workflow for Human Serum by Phospholipid Removal and LC–HRMS Analysis in Multiwell Plates (P-46)
    Bénilde Bonnefille — Department of Environmental Science, Exposure and Effects Unit, Science for Life Laboratory, Stockholm University, Stockholm, Sweden; +
  • Matrix-resolved profiling of the prenatal chemical exposome reveals selective placental retention and fetal transfer (P-47)
    Montse Marquès — Environmental Chemistry, Institute of Environmental Assessment and Water Research (IDAEA-CSIC); +
  • Characterization of the pregnancy chemical exposome via wide-scope screening of 200 placenta samples (P-48)
    Ana González-Ruiz — Institute of Environmental Assessment and Water Research (IDAEA-CSIC), Department of Environmental Chemistry; +
  • Innovative technology for deciphering the exposome (P-49)
    na — na;
  • Dried blood spot exposomics: an EIRENE-AT approach for early-life large-scale exposure assessment in newborns (P-50)
    Maximilian Zeyda — Department of Pediatrics and Adolescent Medicine, Comprehensive Center for Pediatrics, Medical University of Vienna, Vienna, Austria.; +
  • Surface dental enamel as a biological matrix to assess past lead exposure in neurodevelopmental disorders: a report of 7 cases. (P-51)
    Domingues; +
  • Librarian: an open-access web application for high-resolution mass spectral library assembly (P-52)
    Jacob Ahlberg Weidenfors — Unit of Integrative Metabolomics, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden; +
  • Enhanced High-Throughput Metabolomics targeting the Aging Exposome: Development of a 1100-Metabolite Platform for Frailty Biomarker Discovery (P-53)
    Meryl Cruz — Biomarkers and Nutrimetabolomics Laboratory, Department of Nutrition, Food Sciences and Gastronomy; +
14.00 - 14.30 h Group 2.6. Occupational exposome (Martine Vrijheid)
Hall Auditorium
  • Quantifying Human Exposome Burden Linked to Toxicant Use in the Processing of Cow Skin Meat (P-24)
    Utah, Julliet Onyemaechi — Department of Environmental Management and Toxicology, Michael Okpara University of Agriculture, Nigeria;
  • Weighting the exposome: a model for Asbestos-Related Disease Prevention (P-25)
    Olga Strogovets — Department of Clinical and Molecular Sciences, Polytechnic University of Marche, Ancona, Italy; +
  • Distinct Occupational Exposures and Convergent Metabolic Disruptions in Wildfire Brigade Members and Fashion Jewelry Welders (P-26)
    Vinícius Guimarães Ferreira — 1 Departamento de Saúde Ambiental, Faculdade de Saúde Pública, Universidade de São Paulo, São Paulo, Brasil; +
  • Dried Blood Spot-Based Monitoring of Immune and Epigenetic Biomarkers in Occupational Exposure Studies (P-27)
    Evi De Ryck — Department Public Health and Primary Care, Centre for Environment and Health, Katholieke Universiteit Leuven, Leuven, Belgium; +
  • Occupational Exposure to Toxic and Potentially Toxic Elements in Amazon Wildfire Brigade Members: Preliminary Evidence of Oxidative Metabolic Alterations (P-28)
    Elizeu Chiodi Pereira — Departamento de Saúde Ambiental, Faculdade de Saúde Pública, Universidade de São Paulo, São Paulo, Brasil; +
14.00 - 14.30 h Group 2.7. Microbiome 2 (Ville Pimenoff)
Tramuntana Room
  • Biom4Health: a microbiota-derived health index for European cohorts using machine learning approach and biological interpretability (P-170)
    Carlos Daviña-Núñez — Galicia Sur Health Research Institute (IIS Galicia Sur), SERGAS-UVIGO; +
  • The role of dietary and mycotoxin exposure on gut microbiota and low-grade gut inflammation in Flemish adults (P-171)
    Arnau Vich Vila — Laboratory of Molecular Bacteriology, VIB-KU Leuven, 3000 Leuven, Belgium; +
  • Multi-element exposure and gut microbiota in postpartum women (P-172)
    Tiago Noronha — CHRC, Department of Metabolism and Nutrition, NOVA Medical School, Faculdade de Ciências Médicas, NMS|FCM, Universidade NOVA de Lisboa; +
  • Longitudinal study of the microbiome associated with particulate matter PM2.5 during severe and non-severe air pollution events in Medellín, Colombia (P-173)
    Andres Puerta González — Universidad EAFIT; +
  • ASSOCIATION OF FAECAL AND URINARY MICRO- AND NANOPLASTICS WITH MARKERS OF GUT INTEGRITY AND RENAL FUNCTION (P-174)
    Emma Calikanzaros — ISGlobal; +
  • ASSOCIATIONS OF GOOD AND BAD LPS SUBTYPES WITH BRAIN HEALTH IN MIDDLE AGED ADULTS (P-175)
    Rafael Tume — Biomarkers and Nutrimetabolomics Laboratory, Department of Nutrition, Food Sciences and Gastronomy, Faculty of Pharmacy and Food Sciences, University of Barcelona, Barcelona, Spain; +
  • Exposure to micro- and nanoplastics is associated with shifts in the gut microbiome of healthy human adults (P-176)
    Emma Calikanzaros — ISGlobal; +
  • Integrated biological and chemical wastewater surveillance reveals local changes in human biotic and abiotic exposome (P-177)
    Anna J. Székely — Swedish University of Agricultural Sciences, Uppsala, Sweden; +
14.00 - 14.30 h Group 2.8. Exposome concepts and health impact (Fenna Sillé)
Tramuntana Room
  • Environmental determinants of healthcare utilizations: multiscale statistical analyses in French territories (P-117)
    Jean-Baptiste Guimbaud — Meersens; +
  • The National Hospital Service for Environmental Medicine (SHNME) at CHEM – a new medical discipline in Luxembourg embedded in the law (P-118)
    An Van Nieuwenhuyse — Laboratoire national de santé (LNS), Department Health Protection, 1 Rue Louis Rech, L-3555 Dudelange, Luxembourg; +
  • Individualism versus Health Equity in Exposomics (P-119)
    CW Safarlou — Department of Global Public Health & Bioethics, University Medical Center Utrecht; +
  • Mapping the Internal Exposome and Early Biological Responses in the HERACLES (Exposome and Health) Study (P-120)
    Maria Nefeli Georgaki —  Aristotle University of Thessaloniki, Department of Chemical Engineering, Environmental Engineering Laboratory, University Campus, Thessaloniki 54124, Greece; +
  • Human Exposome Foundation: Supporting the Integration of Exposomics into Biomedical Research (P-121)
    Zhen Xiao — Human Exposome Foundation, Inc; +
  • ENVIRONMENTAL STRESSORS AS CAUSAL DETERMINANTS FOR IMMUNE-MEDIATED DISEASES - MAPPING AND PRIORITIZING EVIDENCE FOR KNOWLEDGE-BASED POLICY MAKING IN THE EU-PROJECT EXPOSIM (P-122)
    Exposim — consortium;

Poster presentations 3

14.30 - 15.00 h Group 3.1. Urban Exposome & Child Health (Juan Carlos Rivillas)
Tramuntana Room
  • Residential noise exposure and children’s emotional and behavioral difficulties: results from the French ELFE birth cohort (P-132)
    Gwendall PETIT — Unité de Mixte de Recherche en Acoustique Environnementale (UMRAE) - Université Gustave Eiffel; +
  • Neighborhood walkability and the association with children’s mental and behavioral difficulties in the ELFE cohort (P-133)
    Eloi CHAZALES — Department of Social Epidemiology, Mental Health and Addictions; +
  • Fine particulate matter, nitrogen dioxide, and Tdap vaccine antibody levels in Mexican children (P-134)
    Maayan Yitshak-Sade — Department of Environmental Medicine, Icahn School of Medicine at Mount Sinai; +
  • Lifetime urban exposure, socioeconomic position and respiratory health of adolescents (P-135)
    Alicia Guillien — University Grenoble Alpes, INSERM U1209, CNRS UMR 5309, Institute for Advanced Biosciences (IAB), Team of Environmental Epidemiology Applied to Development and Respiratory Health, Grenoble, France; +
  • Prenatal indoor and outdoor heat exposure, fetal brain morphological development, and early childhood neurodevelopment: preliminary results (P-136)
    Yu Zhao — ISGlobal; +
  • Prenatal Exposure to Air Pollution and Fetal Cardiac Morphology and Function: preliminary results (P-137)
    Yana Luo — ISGlobal, Barcelona, Spain; +
  • The social and physical exposome and child cognition: a multi-cohort study (P-138)
    Payam Dadvand — ISGlobal; +
  • Prenatal urban exposome and asthma up to adolescence: A multicenter study (P-139)
    Zeinab Tarhini — University Grenoble Alpes, INSERM U1209, CNRS UMR 5309, Institute for Advanced Biosciences (IAB), Team of Environmental Epidemiology Applied to Development and Respiratory Health, Grenoble, France; +
14.30 - 15.00 h Group 3.2. Chemical Exposome & Reproductive Outcomes (Léa Maitre)
Tramuntana Room
  • Exposure to Pesticides and Metals is Associated with Adverse Female Reproductive Outcomes (P-87)
    Miaofeng Cao — Department of Environmental Science, Zhejiang University; +
  • Mental Health, Lived Experiences, and Coping Within the Infertility Exposome Among Lebanese Women: A Mixed-Methods Triangulation Study (P-88)
    Myriam Mrad — Public Health Department, Faculty of Health Sciences, University of Balamand, Beirut, Lebanon; +
  • Biological age acceleration through molecular clocks and its relation with pubertal timing in European children. (P-89)
    Alvaro Torres — Department of Biochemistry and Molecular Biology II, Institute of Nutrition and Food Technology 'José Mataix,' Center of Biomedical Research, University of Granada, Granada, Spain.; +
  • Mapping the chemical exposome of endometriosis using high-resolution mass spectrometry and bioinformatic tools : from individuals to populations (P-90)
    German Cano-Sancho — Oniris, INRAE, LABERCA, Nantes, France; +
  • Exposomics Identifies Internal Pollutant Exposures Associated with Urinary Steroid Hormone Disruptions in Older Adults: The China BAPE Study (P-91)
    Chenlong Li — NIEH, China CDC; +
  • An integrated exposome risk prioritization strategy for disease-specific substance priority listing: Preeclampsia as a proof-of-concept (P-92)
    Tianrui Gao — School of Public Health, Anhui Medical University; +
  • Chemical exposome and endometriosis risk in a French population-based cohort: a prospective study targeting persistent organic pollutants (P-93)
    Sabine Naudin — Epidemiology of Gyneacological Health Team, UPS, UVSQ, Inserm, Gustave Roussy, CESP, 94800, Villejuif, France; +
14.30 - 15.00 h Group 3.3. Exposome & Cancer (Michelle Turner )
Tramuntana Room
  • Survival of oral and oropharyngeal cancers in the USA: An exposome-wide analysis using hospital-based cancer registries data (P-155)
    Krithiga Shridhar — Cancer Epidemiology, Centre fro Chronic Disease Control, New Delhi, India.; +
  • Epigenome-wide Association Study of Lung Adenocarcinoma in Never-Smokers from Taiwan (P-156)
    Chi-Jen Chen — Institute of Epidemiology and Preventive Medicine, National Taiwan University College of Public Health, Taipei, Taiwan; +
  • An Exposomic Perspective on HIV–Helminth Coinfections, Socioeconomic, Biological and Immune Dysregulation Interactions and Colorectal Cancer Risk (P-157)
    Dlamini Z — PACRI, UP; +
  • Environmental Inequity and Cancer Prognosis: an Urban Exposome Cohort Study (P-158)
    Nuria Pastor-Ibáñez — Barcelona Institute for Global Health; +
  • Breast cancer immunophenotypes are associated with exposure to mixtures of organochlorine pesticides and trace elements among Northern Mexican women (P-159)
    Ángel Mérida-Ortega — Center for Population Health Research, National Institute of Public Health; +
  • MultiRISCCanSein: Protocol for assessing exposures to ionizing radiation and chemicals in relation to breast cancer risk in the E3N cohort (P-160)
    ;
  • Microplastic Profiling in Lung Cancer Patients and Healthy Controls (P-161)
    Abhinav Kaushik — T.H. Chan School of Public Health, Harvard University; +
14.30 - 15.00 h Group 3.4. Model systems (Xavier Coumoul)
Hall Auditorium
  • Bridging Environment to Exposome: In Vitro Evidence for Chemical Mixture Propagation to Humans (P-19)
    Beate Escher — Department of Cell Toxicology, Helmholtz Centre for Environmental Research – UFZ; +
  • Integrating PBPK modelling into exposome research to improve exposure interpretation (P-20)
    Ratier Aude — Ineris; +
  • Fungicide exposure differentially affects Alzheimer’s disease marker aggregation in two transgenic mouse models (P-21)
    Gaëlle Dudon — Inserm, Institut des Neurosciences de Montpellier; +
  • Deciphering the Effects of Air Pollution on Lung Health Using Human Bronchial Epithelial Cell models (P-22)
    Jordi Puigdemasa — Department of Environmental Chemistry. Institute of Environmental Assessment and Water Research (IDAEA-CSIC); +
  • Impact of Eight Bisphenol A Substitutes on the Viability and Oxidative Stress of Human Keratinocytes and Hepatic Cells (P-23)
    Nicoli Gomes de Moraes — University of São Paulo (Center for Nuclear Energy in Agriculture); +
14.30 - 15.00 h Group 3.5. Mass-spectrometry methods 2 (Pablo Gago Ferrero)
Hall Tramuntana
  • Non-Target Screening based Clustering Analysis of Chemical Fingerprints in Austrian Surface Waters (P-64)
    Jacqueline Meng-Reiterer — Evironment Agency Austria; +
  • Building a Galaxy Exposome Toolbox for mass spectrometry data processing (P-65)
    Biomarker Analytical Laboratories — RECETOX, Faculty of Science, Masaryk University, Kotlářská 2, 60200 Brno, Czech Republic;
  • Ion-mobility derived Collision Cross Section values: An emerging tool for improved annotation confidence in exposomics studies (P-66)
    Maosen Zhao — Toxicological Centre, University of Antwerp, Belgium; +
  • Comprehensive PFAS Biomonitoring by LC-MS/MS: Method Validation and Serum–Plasma Comparability (P-67)
    Maria-Mirela Ani — Laboratoire national de santé (LNS), Department Health Protection, Service Environmental Hygiene and Human Biological Monitoring; +
  • A rapid and robust GC-HRMS workflow for the determination of persistent organic pollutants (POPs) in exposome-wide association studies (ExWAS) (P-68)
    Delia Castilla-Fernández — Department of Food Chemistry and Toxicology, Faculty of Chemistry, University of Vienna, Währinger Str. 38, A-1090 Vienna, Austria; +
  • Development of a Semiquantitative Framework for Nontarget Screening of Emerging Contaminants in Human Matrices (P-69)
    Ruben Gil-Solsona — Institute of Environmental Assessment and Water Research (IDAEA), Carrer Jordi Girona 18-26, Barcelona, 08034, Spain, Barcelona, Catalonia, Spain; +
  • Development of a standardized method based on untargeted metabolomics for the analysis of placentas from mother-child cohort studies (P-70)
    Thomas Contini — Univ Rennes, CHU Rennes, Inserm, EHESP, Irset (Institut de Recherche en Santé, Environnement et Travail) - UMR_S 1085, F-35000 Rennes, France; +
14.30 - 15.00 h Group 3.6. External exposome - methods (Justiina Ronkainen)
Hall Auditorium
  • An informed machine learning based environmental risk score for hypertension in European adults (P-29)
    Jean-Baptiste Guimbaud — Meersens; +
  • Reconstruction of the radiological component of the exposome in the CONSTANCES cohort as part of the CORALE project. (P-30)
    Philippe‎ Renaud — ASNR/PSE-ENV; +
  • ExpoMapper: an interactive tool for generating environmental exposures from individual-level geographic coordinates (P-31)
    Justiina Ronkainen — Research Unit of Population Health, University of Oulu, Finland; +
  • ETAIN 5G Scientist app adapted use: A preliminary study on pregnant women's RF-EMF exposure in a South-American city. (P-32)
    Domingues; +
  • The Environmental Exposome and Health (ENVESOME): A multi-omics framework for precision prevention and public health protection (P-33)
    - — -;
  • Characterizing Human-Environment Exposome Relationships Across NC counties (2010 - 2020) (P-34)
    Arcot Rajasekar — University of North Carolina at Chapel Hill;
  • The Global Light Commons: An infrastructure and community framework for light exposure in human exposome research (P-35)
    Salma M. Thalji — Professorship of Chronobiology & Health, Department of Sport and Health Sciences, Technical University of Munich; +
  • Ambient and indoor/outdoor exposure to ultrafine particles in Switzerland: an update on the MARKOPOLO project (P-36)
    Eric Twomey — Swiss Tropical and Public Health Institute, Allschwil, Switzerland; +
14.30 - 15.00 h Group 3.7. Data analytics (Augusto Anguita Ruiz)
Tramuntana Room
  • Fluxomics for exposomics: Digital twinning and in silico intervention design for unravelling exposure-outcome causality (P-140)
    Daniel Fässler — University Medicine Greifswald (Department of Psychiatry and Psychotherapy; +
  • Navigating Variable Selection And Mixture Identification: A Comprehensive Simulation Study With Mixture Models (P-141)
    Nicolas Jovanovic — University Grenoble Alpes, Inserm U-1209, CNRS-UMR-5309, Environmental Epidemiology Applied to Reproduction and Respiratory Health Team, Institute for Advanced Biosciences,38000, Grenoble, France; +
  • A weight-of-evidence and meta-analysis-informed Bayesian analysis to limit False Discovery Rate in Exposome studies (P-142)
    Mustieles Vicente — Hospital Universitario Clínico San Cecilio, Servicio de Radiodiagnóstico, Granada, Spain. Instituto de Investigación Biosanitaria (ibs.GRANADA), Granada, Spain. University of Granada, Center for Biomedical Research (CIBM), Spain; +
  • Leveraging Artificial Intelligence to Illuminate the “Dark Matter” of the Exposome Discovery (P-143)
    Changzhi Shi — Fudan University;
  • Artificial Intelligence–Driven Integration of Epigenomic and Exposome Data for Early-Life Environmental Health Risk Assessment (P-144)
    Prisco Piscitelli — Italian Society of Environmental Medicine, Milan, Italy; +
  • Network integration of GWAS and air‑pollution EWAS to prioritize gene–environment interactions in asthma and T2D (P-145)
    Alan Kim — EHE, Johns Hopkins Bloomberg School of Public Health; +
  • Critical window detection for air pollution exposure during pregnancy with causal random forests (P-146)
    Simon C. Brewer — Environment, Society & Sustainability, University of Utah; +
  • Mapping Analytical and Computational Methods in Exposomics: Lessons from a Comparative Multi-Omics Survey Analysis (P-147)
    Krystal Pollitt, Department of Environmental Health Sciences, Yale University Jeremy P. Koelmel, Department of Environmental Health Sciences, Yale University Fanny Chu, Biological Sciences Division, Pacific Northwest National Laboratory Randolph Singh, Department of Environmental Health Sciences, Columbia University Thomas O. Metz, Biological Sciences Division, Pacific Northwest National Laboratory;
14.30 - 15.00 h Group 3.8. Exposome reviews (Amélie Crepet)
Tramuntana Room
  • The role of the exposome in mental health: a scoping review (P-110)
    Claudia Gutierrez-Ortiz — Socio-economic, Environmental Health & Health Services (CARES) Research Unit, Department of Precision Health, Luxembourg Institute of Health; +
  • Integrating genetic and epigenetic biomarkers into human biomonitoring for next-generation health risk assessment (P-111)
    Mathieu Gand — Transversal Activities in Applied Genomics, Sciensano; +
  • Exposome and chronic lung diseases: a systematic review protocol (P-112)
    Alícia Josa-Culleré — ISGlobal, Barcelona, Spain; +
  • Exploring the Exposome research in Sub-Saharan Africa: Insights from Ethiopia, Malawi, South Africa and Uganda (P-113)
    Andrew Matchado — Nutrition and Dietetics Department, School of Global and Public Health, Kamuzu University of Health Sciences; +
  • Mapping the Evidence for Exposome Research and Alzheimer’s Disease and Related Dementias (P-114)
    Thomas J. Luben; +
  • Exposome Research for Global Impact: Future Priorities in Low- and Middle-Income Countries (P-115)
    Io Hong Cheong — School of Public Health, Shanghai Jiao Tong University, Shanghai, China; +
  • Environmental determinants of type 1 diabetes - decoding the exposome (P-116)
    Maurane Rollet — Deep Digital Phenotyping Research Unit, Department of Precision Health, Luxembourg Institute of Health, Strassen, Luxembourg; +

Speakers

Day 2, 28th April 2026

Cathryn Tonne
Research Professor; Climate, Air Pollution, Nature and Urban Health; Barcelona Institute for Global Health (ISGlobal), Spain

Keynote 1: Climate action as a driver of healthier exposomes

Cathryn Tonne is an environmental epidemiologist focusing on the health effects of air pollution from outdoor and household sources and their intersection with sustainable development. Her research has investigated exposure patterns and health effects of air pollution in high- as well as low- and middle-income countries.

One of her main research interests is in the health co-benefits of climate change mitigation. She is co-director of the Lancet Countdown for Health and Climate Change in Europe and leads the working group focused on mitigation actions and health co-benefits.

Jonathan Martin
Professor and Unit Head of Exposure and Effects Unit (ACESx), Department of Environmental Science, Stockholm University, Sweden

Keynote 2: From Sample to Molecules to Meaning: High-Resolution Chemical Exposomics for Precision Health

Professor and Unit Head of the Exposure and Effects Unit (ACESx), Department of Environmental Science, Stockholm University, Sweden. He is also Scientific Director of the National Facility for Exposomics, Metabolomics and Exposomics Platform, SciLifeLab, Sweden. Jonathan Martin's research focuses on the chemical exposome, and specifically on the development of methods to measure it in health and exposure studies. His research group develops new methods for environmental sampling and sample preparation, and combines these with combined target/nontarget high-resolution mass spectrometry (HRMS) workflows to discover the complex mixture of small molecules in our bodies and in the environment around us.

Jinhee Choi
Professor of Environmental Toxicology, University of Seoul, South Korea

Keynote 3: Integrating Consumer Product-Based Exposure with AOP-Anchored AI-Based Toxicity Prediction for Exposome-Informed Chemical Prioritization

Dr. Jinhee Choi is Professor of Environmental Engineering at the University of Seoul and Director of the Chemical Big Data Science AI Research Center. Her research bridges ecotoxicology, human toxicology, and computational toxicology, integrating mechanistic toxicology and data science to advance New Approach Methodologies (NAMs) and Next-Generation Risk Assessment (NGRA) under a One Health framework. She has developed AOP-informed and explainable AI approaches for toxicity prediction, chemical mixture risk assessment, and regulatory applications in consumer product and environmental safety. A former President of the Korean Society of Environmental Toxicology and Health and advisor to the Korean Presidential Advisory Council on Science and Technology, she was recognized as a Highly Cited Researcher in Toxicology (2015–2017). Her work emphasizes transparency, interpretability, and the integration of human and environmental health in modern chemical safety assessment.

Kees de Hoogh
Researcher, Institute for Risk Assessment Sciences (IRAS), Utrecht University, Netherlands

Keynote 4: Advances in Spatiotemporal Modelling for External Exposome Assessment

His scientific research focuses on spatial modelling and exposure assessment for studies on environment and health. His recent focus involves cutting edge fine resolution spatio-temporal modelling to derive refined exposures using satellite and ancillary data. He has been involved in a number of large projects (BioSHARE, ESCAPE, ELAPSE) where he co-led the air pollution exposure assessment, and currently is a co-PI of the European research project EXPANSE, the NWO Gravitation programme Exposome-NL, the Utrecht Exposome Hub and PI of MOBI-AIR studies.

Joaquin Migeot
Neuroscientist, Latin American Brain Health Institute (BrainLat), Universidad Adolfo Ibañez, Chile. Global Brain Health Institute (GBHI), Trinity College Dublin, Ireland

Keynote 5: Unequal exposomes shaping global brain health

Joaquín Migeot is a researcher at the Latin American Brain Health Institute (BrainLat), Universidad Adolfo Ibáñez, where he leads research at the intersection of social determinants of health, cognitive aging, and equity in brain health across Latin America. He is also an Global Brain Health Institute (GBHI) Atlantic Fellow for Equity in Brain Health. He has authored over 25 peer-reviewed publications in leading international journals, including Nature Medicine, Nature Communications, Nature Aging, Trends in Neurosciences, and Alzheimer’s & Dementia. His work integrates social determinants of health, exposome science, and neurobiological markers to understand how structural inequality and lived environments shape brain aging and dementia risk. He contributes to large-scale regional collaborations, including the ReDLat Consortium, where he collaborates in the integration and analysis of social, clinical, cognitive, and neuroimaging datasets across multiple Latin American countries.

Tanya Alderete
Associate Professor, Bloomberg School of Public Health, Johns Hopkins University, USA

Keynote 6: From Exposures to Outcomes: A Multi-Omics Window into the Infant Gut Microbiome

Dr. Tanya Alderete's current research is centered on the intersection of environmental exposures, metabolic health, and the human microbiome, with a focus on obesity and type 2 diabetes. Dr. Alderete employs a multidisciplinary approach, integrating clinical research, epidemiological methods, and omics techniques to explore how environmental factors contribute to chronic diseases.

Call for Abstracts

On behalf of the Scientific Committee, we invite abstracts describing ongoing and completed work related to the human exposome and exposomics.

Abstracts should report original results from studies and not merely describe a study design. Submissions from all summit participants are encouraged, including those related to industry, NGOs, and other organisations. We do not require exclusive submission.

The majority of accepted abstracts will be presented as posters. A small number will be selected for plenary oral presentation. Abstracts will be published in an abstract book and made available to all summit participants.

Abstract submission deadline is 14th January 2026 by 23:59 Central European Time (CET).

We welcome abstract submissions for late-breaking posters until February 28th, 23:59h CET.

The results of the selection process will be communicated to the presenting author by 2nd February 2026.

Please use the same e-mail address for submitting your abstract as you used for registering for the meeting.

Important for abstract submission:

  • Abstracts should report original research results.
  • All abstracts must be submitted online through the abstract submission system by the deadline above.
  • Authors may submit more than one abstract for consideration, but please do not submit multiple copies of the same abstract.
  • The submitting author is required to ensure that all coauthors agree with the submitted version of the abstract.
  • Final decision on abstract acceptance and oral presentation will be made by the Scientific Committee.

Abstract guidelines:

  • All abstracts must be written in English.
  • Use acronyms only when strictly necessary and all non-standard abbreviations must be spelt-out at their first use.
  • Abstract titles should be limited to 20 words.
  • Abstract body should not exceed 300 words and structured in: Objective, Methods, Results, Conclusion.
  • Images, tables, diagrams and graphs will not be accepted as a part of the abstract.
  • Once submitted, an abstract can not be edited.

Review Process and Acceptance Notification:

  • All submitted abstracts will be reviewed by members of the scientific committee of the summit. A small number of abstracts will be selected for plenary oral presentation.
  • Notification of abstract acceptance, including presentation type, will be sent to the presenting author´s email address.

Registrations

Accommodation

Official Congress Hotel: Meliá Sitges

Hotel Meliá Sitges ****
Carrer de Joan Salvat Papasseit, 38
08870. Sitges (Barcelona)
Web: Hotel link

A special rate has been arranged for event participants. Please note that this option will be available until we reach the capacity of rooms arranged with the hotel.
Therefore, we encourage participants to arrange accommodation along with the registration.
Upon accommodation booking, participants will obtain an email confirmation with the recepit of payment. The official invoice for the accommodation will be issued directly by the hotel to the guest at the time of check-out.

Room Price
Double room for single use 213.32 €
Per night, breakfast and taxes included.


To benefit from these accommodation rates, the booking must be submitted through the online registration form and processed together with the congress registration.

Event venue

The Venue

Hotel Meliá Sitges
Carrer de Joan Salvat Papasseit, 38
08870. Sitges (Barcelona)
Web: Hotel link

How to get there?

From Barcelona city

By train

  • You can take the train R2 heading south of Rodalies de Catalunya (regional rail system) from either Barcelona-Passeig de Gracia or Barcelona-Sants stations and takes about 45 mins. From the Sitges station the hotel is 20 min walk or take a taxi for about 7-8€.

From the airport (Terminal 1)

There are three main ways to get there:

By Taxi

  • Getting to Sitges from Barcelona airport by taxi will take about 30 minutes and cost 75-85€.

By train

  • Take the internal airport bus that takes you to Terminal 2, where you can get the train or metro (both to El Prat de Llobregat), then take the train R2 heading south towards Vilanova i la Geltrú and arrive to Sitges after six stops and then take a taxi to the hotel (7-8€) or a bus SL3 from the train station to Hotel Melia Sitges after four stops.

Bus Garraf

  • Located in Terminal 1 floor 0, and it is between bus stops 7 and 11. On Sundays leaves every hour from 8:05h to 23:05h and takes 55 mins. During the week, the bus runs from 5.20 to 23.50h and also leaves every hour, but from 11 to 17h departs every half hour, and takes 35 mins. You can get off at Can Robert in Sitges, where you can take a taxi to the hotel (7-8€) or catch bus SL3 from the train station to Hotel Melia Sitges after four stops.

The following organizations have contributed travel awards for event participants:

L'Oréal

Contact

Technical Secretariat

Acto Serveis

PARC TECNOCAMPUS MATARÓ-MARESME EDIFICI TCM2
Planta 2. O3.
Carrer d'Ernest Lluch, 32,
08302 Mataró, Barcelona +34 937 552 382
congresos@actoserveis.com
www.actoserveis.com

Cookies

We use our own and third-party cookies to improve our services and show you advertising related to your preferences by analyzing your browsing habits.
Following article 22.2 of Law 34/2002, of July 11, on services of the information society and electronic commerce, we ask for your permission to obtain statistical data on your browsing on this website. View Cookies policy.

Cookies used

Accept all Aceptar seleccionadas Reject cookies

Name Supplier Utility Expiration Category
PHPSESSID www.actoserveis.com Identifier associated with the user's session. Used to preserve the user's state while browsing the web Session Necessary
cookie-config www.actoserveis.com Save cookie settings 1 month Necessary
_ga Google Analytics Distinguish users 2 years Statistics
_ga_* Google Analytics Maintain session state 2 years Statistics